Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KONTINUE: Long-term Ivacaftor in CF
NCT01707290Phase 3Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Feb 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of ivacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started Feb 2013; status: completed.
02
Drugs
ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01707290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01707290.